Intensified perfusion processes are a key component in Integrated Continuous Biomanufacturing that still faces many challenges. For example, delivering the right amount of nutrients for extremely high cell densities at economically feasible perfusion rates need the right cell culture media and process development. To this end, data sets are generated using high-throughput small-scale models. In the absence of a cell retention device that can work with those small working volumes, strategies that mimic perfusion are being used. For example, a common technique is to use either high density batch or simulation of perfusion in spin tubes or ambr®151 using discrete media exchanges. However, the applicability of the data generated in these small-...
Session proposals: Towards other cell lines and systems – opportunities and challenges beyond CHO c...
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufac...
In recent years a strong trend towards continuous biopharmaceutical processing has gathered momentum...
Perfusion technology has been successfully used for the commercial production of biotherapeutics, in...
For over 75 years, continuous manufacturing has been investigated in both academia and industry as a...
Continuous manufacturing has been investigated in both academia and industry as an alternative to ba...
The continuous production of biopharmaceuticals combines several advantages: the use of smaller equi...
The maturation of biopharmaceutical process understanding and technical advances have paved the way ...
Reaching cell densities higher than 80 million with the minimum possible perfusion rates is a goal f...
An increasing number of biopharmaceutical companies are employing intensified perfusion as a means t...
We present an integrated microfluidic bioreactor for fully continuous perfusion cultivation of suspe...
The ambr® 250 bioreactor system (Sartorius Stedim) has become a useful tool for CHO cell culture pro...
In recent years a strong trend towards intensified and continuous biopharmaceutical processing has g...
Biopharmaceutical industry is facing numerous challenges. Increased cost pressure, changing markets,...
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufac...
Session proposals: Towards other cell lines and systems – opportunities and challenges beyond CHO c...
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufac...
In recent years a strong trend towards continuous biopharmaceutical processing has gathered momentum...
Perfusion technology has been successfully used for the commercial production of biotherapeutics, in...
For over 75 years, continuous manufacturing has been investigated in both academia and industry as a...
Continuous manufacturing has been investigated in both academia and industry as an alternative to ba...
The continuous production of biopharmaceuticals combines several advantages: the use of smaller equi...
The maturation of biopharmaceutical process understanding and technical advances have paved the way ...
Reaching cell densities higher than 80 million with the minimum possible perfusion rates is a goal f...
An increasing number of biopharmaceutical companies are employing intensified perfusion as a means t...
We present an integrated microfluidic bioreactor for fully continuous perfusion cultivation of suspe...
The ambr® 250 bioreactor system (Sartorius Stedim) has become a useful tool for CHO cell culture pro...
In recent years a strong trend towards intensified and continuous biopharmaceutical processing has g...
Biopharmaceutical industry is facing numerous challenges. Increased cost pressure, changing markets,...
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufac...
Session proposals: Towards other cell lines and systems – opportunities and challenges beyond CHO c...
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufac...
In recent years a strong trend towards continuous biopharmaceutical processing has gathered momentum...